Upadhya, Bharathi
Kitzman, Dalane W.
Funding for this research was provided by:
National Institutes of Health (R01AG18915, P30AG12232)
Article History
First Online: 18 March 2017
Compliance with Ethical Standards
:
: Supported in part by NIH grants R01AG18915 and P30AG12232, and by the Kermit Glenn Phillips endowment in cardiovascular medicine.
: Dr. Kitzman declares the following relationships: consultant for Abbvie, Bayer, Merck, Medtronic, GSK, Relypsa, Regeneron, Merck, Corvia Medical, and Actavis, research grant funding from Novartis, and stock ownership in Gilead Sciences and Relypsa, Inc. Dr. Upadhya has received research funding from Novarits and Corvia.